Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Tabata

Showing results (231-240 of 273) with videos related to

Pageof 28
Sort By:
Journal of the American Heart Association|September 17, 2021
Prognostic Value of Ventricular-Arterial Coupling After Transcatheter Aortic Valve Replacement on Midterm Clinical OutcomesHiroaki Yokoyama, Futoshi Yamanaka, Koki Shishido, et al.
The Canadian Journal of Cardiology|May 30, 2020
Clinical Impact of Preprocedural Moderate or Severe Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve ReplacementMizuki Miura, Kyohei Yamaji, Shinichi Shirai, et al.
The American Journal of Cardiology|August 4, 2018
Frequency and Consequences of Cognitive Impairmentin Patients Underwent Transcatheter Aortic Valve ImplantationRyo Yanagisawa, Makoto Tanaka, Fumiaki Yashima, et al.
JACC. Cardiovascular Interventions|November 1, 2020
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVRHideyuki Kawashima, Yusuke Watanabe, Hirofumi Hioki, et al.
BMJ Open|August 20, 2018
Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in JapanKazuki Mizutani, Masahiko Hara, Mana Nakao, et al.
Contemporary Clinical Trials|October 18, 2023
Rationale and design of Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation (NAPT) TrialTaku Inohara, Toshiaki Otsuka, Yusuke Watanabe, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 27, 2021
Balloon Post-Dilatation Improves Long-Term Valve Performance After Balloon-Expandable Valve ImplantationYugo Nara, Yusuke Watanabe, Akihisa Kataoka, et al.
ESC Heart Failure|April 12, 2024
Long-term prognostic value of the H<sub>2</sub>FPEF score in patients undergoing transcatheter aortic valve implantationKenichi Ishizu, Shinichi Shirai, Akihiro Isotani, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 3, 2021
Impact of New York Heart Association Functional Class on Outcomes After Transcatheter Aortic Valve ImplantationTomohiko Taniguchi, Shinichi Shirai, Kenji Ando, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 28, 2021
Effect of Sex on Mortality and Left Ventricular Remodeling After Transcatheter Aortic Valve ImplantationKoki Shishido, Futoshi Yamanaka, Tomoki Ochiai, et al.
Pageof 28

Showing results (231-240 of 273) with videos related to

Sort By:
Pageof 28
Journal of the American Heart Association|September 17, 2021
Prognostic Value of Ventricular-Arterial Coupling After Transcatheter Aortic Valve Replacement on Midterm Clinical OutcomesHiroaki Yokoyama, Futoshi Yamanaka, Koki Shishido, et al.
The Canadian Journal of Cardiology|May 30, 2020
Clinical Impact of Preprocedural Moderate or Severe Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve ReplacementMizuki Miura, Kyohei Yamaji, Shinichi Shirai, et al.
The American Journal of Cardiology|August 4, 2018
Frequency and Consequences of Cognitive Impairmentin Patients Underwent Transcatheter Aortic Valve ImplantationRyo Yanagisawa, Makoto Tanaka, Fumiaki Yashima, et al.
JACC. Cardiovascular Interventions|November 1, 2020
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVRHideyuki Kawashima, Yusuke Watanabe, Hirofumi Hioki, et al.
BMJ Open|August 20, 2018
Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in JapanKazuki Mizutani, Masahiko Hara, Mana Nakao, et al.
Contemporary Clinical Trials|October 18, 2023
Rationale and design of Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation (NAPT) TrialTaku Inohara, Toshiaki Otsuka, Yusuke Watanabe, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 27, 2021
Balloon Post-Dilatation Improves Long-Term Valve Performance After Balloon-Expandable Valve ImplantationYugo Nara, Yusuke Watanabe, Akihisa Kataoka, et al.
ESC Heart Failure|April 12, 2024
Long-term prognostic value of the H<sub>2</sub>FPEF score in patients undergoing transcatheter aortic valve implantationKenichi Ishizu, Shinichi Shirai, Akihiro Isotani, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 3, 2021
Impact of New York Heart Association Functional Class on Outcomes After Transcatheter Aortic Valve ImplantationTomohiko Taniguchi, Shinichi Shirai, Kenji Ando, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 28, 2021
Effect of Sex on Mortality and Left Ventricular Remodeling After Transcatheter Aortic Valve ImplantationKoki Shishido, Futoshi Yamanaka, Tomoki Ochiai, et al.
Pageof 28